SCHEMBL7443673

SCHEMBL7443673

CCCN(CCc1ccccc1)C1CCc2c(ccc3c2C(=O)C(=O)N3)C1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 11/20 0.59
DRD1 P21728 6/20 0.59
DRD3 P35462 6/20 0.59
DRD4 P21917 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
TSHR P16473 1/20 0.59
NFKB1 P19838 1/20 0.59
THPO P40225 1/20 0.59
LMNA P02545 1/20 0.58
PMP22 Q01453 1/20 0.58
HTR1D P28221 3/20 0.55
HTR1B P28222 3/20 0.55
HTR1A P08908 2/20 0.48
HTR7 P34969 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10972719 0.91 HTR1D (0.57) DRD2DRD1DRD3DRD4HTR1D
SCHEMBL8317195 0.83 HTR1D (0.59) DRD2DRD3HTR1DHTR1B
SCHEMBL8887664 0.82 HTR1D (0.66) DRD2DRD3CYP1A2CYP2D6TSHR
SCHEMBL7443670 0.80 DRD2 (0.49) DRD2DRD1DRD3DRD4CYP1A2
SCHEMBL7443661 0.80 DRD2 (0.49) DRD2DRD1DRD3DRD4CYP1A2
SCHEMBL7436234 0.76 HTR1D (0.86) DRD2DRD1DRD3DRD4CYP1A2
SCHEMBL7382314 0.75 DRD2 (1.00) DRD2DRD1DRD3DRD4CYP1A2
SCHEMBL30350387 0.75 DRD2 (1.00) DRD2DRD1DRD3DRD4CYP1A2
Hydrochloric Acid SCHEMBL29496530 0.74 DRD2 (1.00) DRD2DRD1DRD3DRD4CYP1A2
Hydrochloric Acid SCHEMBL7327809 0.74 DRD2 (0.76) DRD2DRD1DRD3DRD4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0690843-B1 Formyl- or cyano- substituted indole derivatives having dopaminergic activity UPJOHN CO (US) 2000-08-30 EP disclosed
US-5639778-A TREATING CENTRAL NERVOUS SYSTEM DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1997-06-17 US disclosed
EP-0690843-A1 INDOLETETRALINS HAVING DOPAMINERGIC ACTIVITY PHARMACIA & UPJOHN COMPANY (US) 1996-01-10 EP disclosed
WO-1994021608-A1 INDOLETETRALINS HAVING DOPAMINERGIC ACTIVITY THE UPJOHN COMPANY (US) 1994-09-29 WO disclosed